⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10938417 | 0.84 | NAALAD2 (0.56) | — | |
| SCHEMBL7314519 | 0.84 | NAALAD2 (0.56) | — | |
| SCHEMBL443229 | 0.84 | NAALAD2 (0.56) | — | |
| SCHEMBL2331463 | 0.82 | — | — | |
| SCHEMBL23567126 | 0.80 | FOLH1 (0.48) | — | |
| SCHEMBL23567127 | 0.80 | FOLH1 (0.48) | — | |
| SCHEMBL8986725 | 0.79 | — | — | |
| SCHEMBL8986730 | 0.79 | — | — | |
| SCHEMBL1922268 | 0.79 | — | — | |
| SCHEMBL2601836 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606711-B2 | Conductive stannic oxide particle-containing organic solvent-dispersed sol and method of production thereof | NISSAN CHEMICAL CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12503514-B2 | Autoimmune suppressor and application thereof | KEYMED BIOSCIENCES CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| CN-120077774-A | Method for forming three-dimensional structure using UV parallel light in multi-layered stacked structure and three-dimensional structure formed by the method | 庆北大学校产学协力团 | 2025-05-30 | — | — | CN | disclosed |
| CN-118679179-B | Long-acting GLP-1 polypeptide compound, composition and application thereof | 内蒙古博睿精创科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20250109302-A1 | CONDUCTIVE STANNIC OXIDE PARTICLE-CONTAINING ORGANIC SOLVENT-DISPERSED SOL AND METHOD OF PRODUCTION THEREOF | NISSAN CHEMICAL CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| CN-119454908-A | Interleukin complex and use thereof | 北京志道生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119270585-A | Photosensitive resin composition, photosensitive resin layer using same, display device, and method for producing photosensitive resin layer | 三星SDI株式会社 | 2025-01-07 | — | — | CN | disclosed |
| CN-119200327-A | Black photosensitive resin composition, black partition wall using same, display device, and method for manufacturing partition wall | 三星SDI株式会社 | 2024-12-27 | — | — | CN | disclosed |
| CN-118696624-B | Method for forming three-dimensional impact absorbing layer using UV parallel light in multi-layered stacked structure and impact absorbing layer formed by the method | 庆北大学校产学协力团 | 2024-12-17 | — | — | CN | disclosed |
| EP-4474355-A1 | ORGANIC SOLVENT DISPERSION SOL CONTAINING CONDUCTIVE STANNIC OXIDE PARTICLES, AND PRODUCTION METHOD FOR SAME | Nissan Chemical Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| WO-2005064008-A9 | METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS | GILEAD SCIENCES INC (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2005064008-A1 | METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| US-20050042536-A1 | Photosensitive resin composition comprising quinonediazide sulfate ester compound | DONGJIN SEMICHEM CO. LTD. (KR) | 2005-02-24 | — | — | US | disclosed |
| EP-1501841-A2 | NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2005-02-02 | — | — | EP | disclosed |
| CN-1475494-A | Cleaning production technique of 16-dehydro pregnenetrolone and its same kind compound | 中国科学院上海有机化学研究所 | 2004-02-18 | — | — | CN | disclosed |
| WO-2003091264-A2 | NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| EP-1228083-A2 | THERAPEUTIC TREATMENT OF ANDROGEN RECEPTOR DRIVEN CONDITIONS | Hollis-Eden Pharmaceuticals Inc. (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001023405-A2 | THERAPEUTIC TREATMENT OF ANDROGEN RECEPTOR DRIVEN CONDITIONS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| US-5167863-A | Ferroelectricity; electrooptic switches | HITACHI, LTD. (JP) | 1992-12-01 | — | — | US | disclosed |
| EP-0322862-A2 | Optically active compounds, their preparation and their use in liquid crystal compositions and liquid crystal optical modulators | HITACHI, LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |